Skip Navigation Links
Centers for Disease Control and Prevention
CDC Home Search Health Topics A-Z




DISSS Home | Contact Us
 Health and Human Services Logo



Animated FirstGov Logo - Click to enter FirstGov


Coccidioidomycosis (Coccidioides immitis) (Valley Fever)

Contents
Home - National Notifiable Diseases Surveillance System
Overview
Introduction
List of Nationally Notifiable Diseases
Alphabetical List of Case Definitions
Definition of Terms
Related Links
References
  Site Search


1995 Case Definition

Clinical description

Infection may be asymptomatic or may produce an acute or chronic disease. Although the disease initially resembles an influenza-like febrile illness primarily involving the bronchopulmonary system, dissemination can occur to virtually any organ system. Confirmation of coccidioidomycosis requires the demonstrated presence of C.immitis by histopathologic, cultural, or molecular means; and/or demonstration of a specific immunologic response (i.e., skin test conversion or demonstration of presence of coccidioidal antibody). The results of these immunologic tests must be interpreted in the context of the varied clinical presentations and the duration and clinical type of coccidioidomycosis.

Clinical case definition

An illness characterized by one or more of the following:
  • Influenza-like signs and symptoms (e.g., fever, chest pain, cough, myalgia, arthralgia, and headache)
  • Pneumonia or other pulmonary lesion, by chest X-ray
  • Erythema nodosum or erythema multiforme rash
  • Involvement of bones, joints, or skin by dissemination
  • Meningitis
  • Involvement of viscera and lymph nodes

Laboratory criteria for diagnosis

Laboratory-confirmed coccidioidomycosis requires one or more of the following:
Cultural, histopathologic, or molecular evidence of presence of C. immitis, or
  • Immunologic evidence of infection
  1. Serologic (testing of serum, cerebrospinal fluid, or other body fluid):
    1. Detection of coccidioidal IgM by immunodiffusion, enzyme immunoassay (EIA), latex agglutination, or tube precipitin, or 
    2. Detection of rising titer of coccidioidal IgG by immunodiffusion, EIA, or complement fixation.
  2. Coccidioidal skin test conversion from negative to positive after the onset of clinical signs and symptoms.

Case classification

Confirmed: a case that meets the clinical case definition and is laboratory confirmed.

See also:

Printable Version

 


 



Privacy Policy | Accessibility

DISSS Home | Contact Us

CDC Home | Search | Health Topics A-Z

This page last updated January 9, 2008

United States Department of Health and Human Services
Centers for Disease Control and Prevention

"Epi Info" is a trademark of the Centers for Disease Control and Prevention (CDC).